$198.52
▼ -0.0% Today
as of Jul 22, 16:50 ET
Last 30 days
Recent Press Releases & News
mixed
▲ 0
● 25
▼ 0
IQVIA Holdings (IQV) Reports Next Week: Wall Street Expects Earnings Growth
IQVIA's Dr. Cynthia Verst Testifies Before Congressional Subcommittee on More Efficient Path to Early Clinical Development in the United States
IQV vs. PEN: Which Stock Is the Better Value Option?
Overview
52-week range
$146
$247
52% of range
Avg surprise (last 3)
+2.0%
Avg reaction (last 3)
+7.8%
67% positive
Latest IV / EM
46%
EM ±10.5% · $200 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 5, 2026 | Mar/2026 | $2.64 | $2.51 | +5.2% | +11.4% | +9.6% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $1.93 | — | — | — | — | financials |
| Tue Jul 22, 2025 | Jun/2025 | $2.53 | $2.50 | +1.2% | — | +17.9% | earnings |
| Tue May 6, 2025 | Mar/2025 | $2.37 | $2.38 | -0.4% | — | -4.0% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $1.55 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $1.97 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $1.56 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $1.63 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $1.59 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Jul 28, 2026 | Jun/2026 | BMO | $2.72 | $2.53 | +7.5% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | $915M | $863M |
| Operating income | $514M | — | $553M | $506M | $496M | — | $550M | $520M |
| Net income | $274M | — | $331M | $266M | $249M | — | $285M | $363M |
| EPS (diluted) | $1.61 | — | $1.93 | $1.54 | $1.40 | — | $1.55 | $1.97 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1.95B | $1.98B | $1.81B | $2.04B | $1.74B | $1.70B | $1.57B | $1.54B |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $6.22B | $6.25B | $5.98B | $6.34B | $5.91B | $5.83B | $5.63B | $5.62B |
| Total assets | $29.68B | $29.94B | $28.73B | $28.63B | $27.32B | $26.90B | $27.18B | $26.40B |
| Long-term debt | $13.99B | $13.88B | $12.79B | $14.18B | $13.11B | $12.84B | $12.29B | $12.09B |
| Total liabilities | $23.33B | $23.31B | $22.44B | $22.85B | $21.34B | $20.83B | $20.21B | $19.68B |
| Total equity | $6.22B | $6.50B | $6.16B | $5.78B | $5.98B | $6.07B | $6.97B | $6.71B |